Quantcast
Tag archive for ‘GlaxoSmithKline’
By Robert Herriman On Friday, September 19th, 2014
0 Comments

Chinese court fines GlaxoSmithKline almost $500 million for paying bribes

A Chinese court imposed a fine of nearly $500 million on the giant British pharmaceutical company GlaxoSmithKline for bribery, according to a New York Times report Friday. Image/CIA The fine of a record 3 billion More...

By The Dispatch On Wednesday, July 16th, 2014
0 Comments

Flu shots: GSK begins shipping of 2014-15 U.S. flu vaccines, FLUARIX® QUADRIVALENT sent to U.S. healthcare providers

GlaxoSmithKline (GSK) announced today it has begun shipping FLUARIX®QUADRIVALENT (Influenza Vaccine) doses to U.S. healthcare providers.  This is the first shipment of GSK’s U.S. flu vaccine supply for the flu More...

By The Dispatch On Wednesday, April 16th, 2014
2 Comments

Diabetes drug, Tanzeum, receives FDA approval

PRESS RELEASE The U.S. Food and Drug Administration Tuesday approved Tanzeum (albiglutide) subcutaneous injection to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes. Type More...

By Robert Herriman On Thursday, September 19th, 2013
1 Comment

GlaxoSmithKline to supply HHS with 60,000 doses of raxibacumab, anthrax antitoxin

The US Department of Health and Human Services (HHS) has announced today the nation’s supply of anthrax antitoxin will be maintained until 2018 under Project BioShield contracts issued by the U.S. Department of More...

By Robert Herriman On Sunday, August 18th, 2013
1 Comment

FDA approves FluLaval Quadrivalent influenza vaccine for persons three years and older

Pharmaceutical, biologics and vaccine company, GlaxoSmithKline (GSK), announced Friday that the Food and Drug Administration (FDA) has approved FluLaval Quadrivalent influenza vaccine for the active immunization More...

By Robert Herriman On Monday, August 12th, 2013
2 Comments

FDA approves Tivicay, a new drug to treat HIV-1 infection

PRESS RELEASE The U.S. Food and Drug Administration today approved Tivicay (dolutegravir), a new drug to treat HIV-1 infection. Tivicay is an integrase strand transfer inhibitor that interferes with one of the enzymes More...

By Robert Herriman On Sunday, May 12th, 2013
0 Comments

Breo Ellipta receives FDA approval for the treatment of COPD

According to the National Heart, Lung and Blood Institute, chronic obstructive pulmonary disease (COPD) is a major cause of disability, and it’s the third leading cause of death in the United States. Currently, More...

By Robert Herriman On Tuesday, December 18th, 2012
1 Comment

GlaxoSmithKline’s Fluarix Quadrivalent receives FDA approval

CDC/ Debora Cartagena The first intramuscular vaccine to cover against four influenza strains has just received US Food and Drug Administration (FDA) approval, according to a GlaxoSmithKline (GSK) press release More...

By Robert Herriman On Tuesday, November 20th, 2012
0 Comments

FDA approves Promacta to treat low platelet counts in hepatitis C patients

The U.S. Food and Drug Administration (FDA) has approved PROMACTA for the treatment of thrombocytopenia (low blood platelet counts) in patients with chronic hepatitis C to allow them to initiate and maintain interferon-based More...


Recent Posts


DISPATCH BLOGS

Grandpa Ernie photo 300x146 Truth in Genesis photo 300x146 Splash Page logo 300x146 Today in History